After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth Patrick Branch Read more
Related Practice Life Sciences & Pharma After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth. 10262020171018
Executive Insights Organization & Performance Disruptive Trends in Corporate Transformation: Converting Ideas Into Action August 23, 2023
Executive Insights Life Sciences & Pharma Diagnostics and Research Tools: Outlook and Industry Trends in 2023 May 26, 2023
Video / Webinar Biotech and Pharmaceuticals Launch Excellence for Biopharma: Planning for Success March 8, 2023
Article Mental and Behavioral Health A Test of Resilience: Looking Forward to Psychedelics Funding in 2023 March 7, 2023
Article Contract/Pharma Services Pharma Contract Services: Turning Challenges Into Advantages December 2, 2022
